Haemophilus influenza type b (Hib) vaccine and its carrier proteins
- PMID: 20607482
- DOI: 10.1007/s12272-010-0600-z
Haemophilus influenza type b (Hib) vaccine and its carrier proteins
Comment on
-
An open-label, single-arm, phase I study to evaluate the safety and immunogenicity of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, in healthy adult volunteers.Arch Pharm Res. 2010 Jun;33(6):919-24. doi: 10.1007/s12272-010-0615-5. Epub 2010 Jul 6. Arch Pharm Res. 2010. PMID: 20607497 Clinical Trial.
Similar articles
-
Haemophilus influenzae type b vaccines: history, choice and comparisons.Pediatr Infect Dis J. 1998 Sep;17(9 Suppl):S113-6. doi: 10.1097/00006454-199809001-00004. Pediatr Infect Dis J. 1998. PMID: 9781742
-
Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.Pediatr Infect Dis J. 1998 Sep;17(9 Suppl):S117-22. doi: 10.1097/00006454-199809001-00005. Pediatr Infect Dis J. 1998. PMID: 9781743 Review.
-
Safety and immunogenicity of Haemophilus influenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age.Indian Pediatr. 2002 May;39(5):427-36. Indian Pediatr. 2002. PMID: 12037271 Clinical Trial.
-
A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.Pediatr Infect Dis J. 2007 Nov;26(11):1057-9. doi: 10.1097/INF.0b013e31813429fa. Pediatr Infect Dis J. 2007. PMID: 17984816 Clinical Trial.
-
Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.Contrib Microbiol Immunol. 1989;10:125-50. Contrib Microbiol Immunol. 1989. PMID: 2684505 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical